XML 107 R89.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Payments (Stock option activity) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Shares      
Outstanding, Beginning Balance (in shares) 3,463,624    
Granted (in shares) 309,974    
Exercised (in shares) (1,201,072)    
Forfeited (in shares) (18,075)    
Outstanding, Ending Balance (in shares) 2,554,451 3,463,624  
Weighted-average Exercise Price Per Share      
Outstanding, Beginning Balance (in dollars per share) $ 51.64    
Granted (in dollars per share) 144.13    
Exercised (in dollars per share) 47.80    
Forfeited (in dollars per share) 65.81    
Outstanding, Ending Balance (in dollars per share) $ 64.43 $ 51.64  
Outstanding, Weighted-average Remaining Contractual Term (in years) 5 years 8 months 12 days    
Outstanding, Aggregate Intrinsic Value [1] $ 258    
Exercisable, December 31, 2020 1,378,614    
Exercisable, Weighted Average Exercise Price Per Share $ 37.05    
Exercisable, Weighted Average Remaining Contractual Term (in years) 3 years 8 months 12 days    
Vested and expected to vest, Aggregate Intrinsic Value [1] $ 177    
Weighted-average grant date fair value per stock option $ 34.22 $ 21.84 $ 20.30
Aggregate intrinsic value on exercise $ 114 $ 76 $ 66
Cash received upon exercise 57 39 36
Share-based Payment Arrangement, Exercise of Option, Tax Benefit $ 39 $ 31 $ 23
[1] Market price of underlying Zoetis common stock less exercise price.